Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ICLR Stock Forecast 2025-2026
$144.96
Current Price
$11.79B
Market Cap
Buy 12
Hold 6
Sell 0
Wall St Analyst Ratings
Distance to ICLR Price Targets
+84.9%
To High Target of $268.00
+42.1%
To Median Target of $206.00
+8.3%
To Low Target of $157.00
ICLR Price Momentum
+5.6%
1 Week Change
-19.0%
1 Month Change
-53.0%
1 Year Change
-30.9%
Year-to-Date Change
-58.3%
From 52W High of $347.72
+8.8%
From 52W Low of $133.28
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching ICON (ICLR) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ICLR and similar high-potential opportunities.
Latest ICLR Stock Price Targets & Analyst Predictions
Based on our analysis of 30 Wall Street analysts, ICLR has a bullish consensus with a median price target of $206.00 (ranging from $157.00 to $268.00). The overall analyst rating is Strong Buy (8.6/10). Currently trading at $144.96, the median forecast implies a 42.1% upside. This outlook is supported by 12 Buy, 6 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Sandy Draper at Guggenheim, projecting a 84.9% upside. Conversely, the most conservative target is provided by Charles Rhyee at TD Cowen, suggesting a 8.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ICLR Analyst Ratings
12
Buy
6
Hold
0
Sell
ICLR Price Target Range
Low
$157.00
Average
$206.00
High
$268.00
Current: $144.96
Latest ICLR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ICLR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 14, 2025 | TD Cowen | Charles Rhyee | Hold | Downgrade | $157.00 |
| Apr 10, 2025 | Barclays | Luke Sergott | Equal-Weight | Downgrade | $165.00 |
| Apr 10, 2025 | Truist Securities | Jailendra Singh | Buy | Maintains | $208.00 |
| Apr 9, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $200.00 |
| Apr 7, 2025 | Citigroup | Patrick Donnelly | Buy | Maintains | $215.00 |
| Mar 21, 2025 | Goldman Sachs | Matthew Sykes | Neutral | Downgrade | $200.00 |
| Mar 4, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $203.00 |
| Feb 21, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $240.00 |
| Feb 13, 2025 | Truist Securities | Jailendra Singh | Buy | Maintains | $262.00 |
| Feb 3, 2025 | JP Morgan | Casey Woodring | Overweight | Maintains | $265.00 |
| Jan 15, 2025 | RBC Capital | Sean Dodge | Outperform | Reiterates | $263.00 |
| Jan 14, 2025 | William Blair | Max Smock | Outperform | Reiterates | $0.00 |
| Jan 7, 2025 | RBC Capital | Sean Dodge | Outperform | Initiates | $263.00 |
| Jan 6, 2025 | Citigroup | Patrick Donnelly | Buy | Maintains | $290.00 |
| Dec 18, 2024 | Truist Securities | Jailendra Singh | Buy | Reiterates | $284.00 |
| Nov 20, 2024 | Baird | Eric Coldwell | Neutral | Maintains | $225.00 |
| Nov 19, 2024 | Leerink Partners | Michael Cherny | Outperform | Reiterates | $255.00 |
| Oct 28, 2024 | Truist Securities | Jailendra Singh | Buy | Maintains | $295.00 |
| Oct 25, 2024 | Barclays | Luke Sergott | Overweight | Maintains | $275.00 |
| Oct 25, 2024 | Leerink Partners | Michael Cherny | Outperform | Maintains | $270.00 |
Icon plc (ICLR) Competitors
The following stocks are similar to ICON based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Icon plc (ICLR) Financial Data
Icon plc has a market capitalization of $11.79B with a P/E ratio of 15.2x. The company generates $8.28B in trailing twelve-month revenue with a 9.6% profit margin.
Revenue growth is -1.2% quarter-over-quarter, while maintaining an operating margin of +17.2% and return on equity of +8.4%.
Valuation Metrics
Market Cap
$11.79B
Enterprise Value
$14.77B
P/E Ratio
15.2x
PEG Ratio
9.6x
Price/Sales
1.4x
Growth & Margins
Revenue Growth (YoY)
-1.2%
Gross Margin
+29.4%
Operating Margin
+17.2%
Net Margin
+9.6%
EPS Growth
+20.1%
Financial Health
Cash/Price Ratio
+4.6%
Current Ratio
1.3x
Debt/Equity
37.8x
ROE
+8.4%
ROA
+4.5%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Icon plc (ICLR) Business Model
About Icon plc
What They Do
Provides clinical research and healthcare intelligence services.
Business Model
Icon plc generates revenue by offering outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device sectors. Their business model focuses on clinical trial management, consulting, and laboratory services, which help clients streamline the development of new healthcare products.
Additional Information
Founded in 1990 and headquartered in Dublin, Ireland, Icon plc plays a significant role in enhancing research accuracy and efficiency through innovative data analytics and digital solutions. The company's expertise in managing large-scale clinical trials enables faster and more cost-effective access to medical advancements, addressing critical global health challenges.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
41,900
CEO
Dr. Steven A. Cutler MBA, Ph.D.
Country
Ireland
IPO Year
1998
Website
www.iconplc.comIcon plc (ICLR) Latest News & Analysis
Latest News
Quick Summary
A class action lawsuit has been filed against ICON Public Limited Company (NASDAQ: ICLR) for securities violations. Investors who bought shares between July 27, 2023, and October 23, 2024, should contact the Schall Law Firm by June 2, 2025.
Why It Matters
A class action lawsuit against ICON may signal potential financial instability or fraud concerns, impacting stock value and investor sentiment regarding the company's future.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Icon PLC (ICLR) is anticipated to lack the necessary factors for a potential earnings beat in its upcoming report. Investors should prepare for the key expectations.
Why It Matters
Lack of key ingredients for an earnings beat may lead to disappointing results for Icon PLC, affecting stock performance and investor sentiment.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
As of 2025, the S&P 500 has entered correction territory, indicating a notable market shift away from the previous bull run driven by growth stocks.
Why It Matters
The shift from a bull run to a correction in the S&P 500 indicates increased market volatility, potentially impacting growth stock valuations and investment strategies.
Source: 24/7 Wall Street
Market Sentiment:
Positive
Quick Summary
A class action lawsuit has been filed against ICON PLC (NASDAQ: ICLR) and some of its officers, as announced by Bronstein, Gewirtz & Grossman, LLC.
Why It Matters
A class action lawsuit against ICON PLC could signal potential financial and reputational risks, impacting stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky, LLP announces a class action lawsuit for ICON Public Limited Company (NASDAQ: ICLR) investors, alleging securities fraud from July 27, 2023, to January 13, 2025.
Why It Matters
A class action lawsuit alleging securities fraud can lead to financial losses for ICON investors and may impact the company's stock price and reputation.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Investors can reach out to a law firm at no charge to explore options for recovering their losses.
Why It Matters
The mention of a law firm offering no-cost consultations suggests potential legal action for investors, indicating possible significant losses and impacting market sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About ICLR Stock
What is Icon plc's (ICLR) stock forecast for 2025?
Based on our analysis of 30 Wall Street analysts, Icon plc (ICLR) has a median price target of $206.00. The highest price target is $268.00 and the lowest is $157.00.
Is ICLR stock a good investment in 2025?
According to current analyst ratings, ICLR has 12 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The stock is currently trading at $144.96. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ICLR stock?
Wall Street analysts predict ICLR stock could reach $206.00 in the next 12 months. This represents a 42.1% increase from the current price of $144.96. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Icon plc's business model?
Icon plc generates revenue by offering outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device sectors. Their business model focuses on clinical trial management, consulting, and laboratory services, which help clients streamline the development of new healthcare products.
What is the highest forecasted price for ICLR Icon plc?
The highest price target for ICLR is $268.00 from Sandy Draper at Guggenheim, which represents a 84.9% increase from the current price of $144.96.
What is the lowest forecasted price for ICLR Icon plc?
The lowest price target for ICLR is $157.00 from Charles Rhyee at TD Cowen, which represents a 8.3% increase from the current price of $144.96.
What is the overall ICLR consensus from analysts for Icon plc?
The overall analyst consensus for ICLR is bullish. Out of 30 Wall Street analysts, 12 rate it as Buy, 6 as Hold, and 0 as Sell, with a median price target of $206.00.
How accurate are ICLR stock price projections?
Stock price projections, including those for Icon plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 28, 2025 5:32 PM UTC